Last updated: January 10, 2024
Sponsor: Peking Union Medical College Hospital
Overall Status: Completed
Phase
N/A
Condition
Speech Disorders
Frontotemporal Dementia
Memory Loss
Treatment
Magstim rTMS
Clinical Study ID
NCT04431401
PPA-rTMS
Ages 35-75 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Clinical diagnosis of PPA
Exclusion
Exclusion Criteria:
- Scored below 15 on the mini-mental state exam (MMSE)
- history of seizures or unexplained loss of consciousness
- pregnancy
- surgical breach of the skull
- MRI contraindication
Study Design
Total Participants: 40
Treatment Group(s): 1
Primary Treatment: Magstim rTMS
Phase:
Study Start date:
July 01, 2020
Estimated Completion Date:
August 31, 2022
Connect with a study center
Peking Union Medical College Hospital
Beijing, Beijing 100730
ChinaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.